Deficiency of PDK1 in Cardiac Muscle Results in Heart Failure and Increased Sensitivity to Hypoxia

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2003 Sep 13

PMID 12970179

Citations 86

Authors

Alfonso Mora

Anthony M Davies

Luc Bertrand

Isam Sharif

Grant R Budas

Sofija Jovanovic

Veronique Mouton

C Ronald Kahn

John M Lucocq

Gillian A Gray

Aleksandar Jovanovic

Dario R Alessi

Affiliations

Soon will be listed here.

Abstract

We employed Cre/loxP technology to generate mPDK1(-/-) mice, which lack PDK1 in cardiac muscle. Insulin did not activate PKB and S6K, nor did it stimulate 6-phosphofructo-2-kinase and production of fructose 2,6-bisphosphate, in the hearts of mPDK1(-/-) mice, consistent with PDK1 mediating these processes. All mPDK1(-/-) mice died suddenly between 5 and 11 weeks of age. The mPDK1(-/-) animals had thinner ventricular walls, enlarged atria and right ventricles. Moreover, mPDK1(-/-) muscle mass was markedly reduced due to a reduction in cardiomyocyte volume rather than cardiomyocyte cell number, and markers of heart failure were elevated. These results suggested mPDK1(-/-) mice died of heart failure, a conclusion supported by echocardiographic analysis. By employing a single-cell assay we found that cardiomyocytes from mPDK1(-/-) mice are markedly more sensitive to hypoxia. These results establish that the PDK1 signalling network plays an important role in regulating cardiac viability and preventing heart failure. They also suggest that a deficiency of the PDK1 pathway might contribute to development of cardiac disease in humans.

Citing Articles

Exosomal Preconditioning of Human iPSC-Derived Cardiomyocytes Beneficially Alters Cardiac Electrophysiology and Micro RNA Expression.

Rosand O, Wang J, Scrimgeour N, Marwarha G, Hoydal M Int J Mol Sci. 2024; 25(15).

PMID: 39126028 PMC: 11313350. DOI: 10.3390/ijms25158460.

3-Phosphoinositide-Dependent Kinase 1 as a Therapeutic Target for Treating Diabetes.

Xiang X, Shuya P, Jiamin Z, Zihan Z, Xumei Y, Jingjin L Curr Diabetes Rev. 2024; 21(4):47-56.

PMID: 38468518 DOI: 10.2174/0115733998278669240226061329.

Identification of biomarkers, pathways, and potential therapeutic targets for heart failure using next-generation sequencing data and bioinformatics analysis.

Ganekal P, Vastrad B, Vastrad C, Kotrashetti S Ther Adv Cardiovasc Dis. 2023; 17:17539447231168471.

PMID: 37092838 PMC: 10134165. DOI: 10.1177/17539447231168471.

Transcriptome Assembly and Analysis of Longevity Genes Using Subterranean Termite () Castes.

Haroon , Li Y, Ye C, Su J, Nabi G, Su X Int J Mol Sci. 2022; 23(21).

PMID: 36362447 PMC: 9657995. DOI: 10.3390/ijms232113660.

Comparative analysis of long noncoding RNA and mRNA expression provides insights into adaptation to hypoxia in Tibetan sheep.

Wang F, Liu J, Zeng Q, Zhuoga D Sci Rep. 2022; 12(1):6597.

PMID: 35449433 PMC: 9023463. DOI: 10.1038/s41598-022-08625-y.

References

Inagaki M, Schmelzle T, Yamaguchi K, Irie K, Hall M, Matsumoto K . PDK1 homologs activate the Pkc1-mitogen-activated protein kinase pathway in yeast. Mol Cell Biol. 1999; 19(12):8344-52. PMC: 84921. DOI: 10.1128/MCB.19.12.8344. View

Sugden P . Signalling pathways in cardiac myocyte hypertrophy. Ann Med. 2002; 33(9):611-22. View

Deprez J, Bertrand L, Alessi D, Krause U, Hue L, Rider M . Partial purification and characterization of a wortmannin-sensitive and insulin-stimulated protein kinase that activates heart 6-phosphofructo-2-kinase. Biochem J. 2000; 347 Pt 1:305-12. PMC: 1220961. View

Williams M, Arthur J, Balendran A, van der Kaay J, Poli V, Cohen P . The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells. Curr Biol. 2000; 10(8):439-48. DOI: 10.1016/s0960-9822(00)00441-3. View

Marber M . Ischemic preconditioning in isolated cells. Circ Res. 2000; 86(9):926-31. DOI: 10.1161/01.res.86.9.926. View

SHIOI T, Kang P, Douglas P, Hampe J, Yballe C, Lawitts J . The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 2000; 19(11):2537-48. PMC: 212739. DOI: 10.1093/emboj/19.11.2537. View

Volarevic S, Thomas G . Role of S6 phosphorylation and S6 kinase in cell growth. Prog Nucleic Acid Res Mol Biol. 2000; 65:101-27. DOI: 10.1016/s0079-6603(00)65003-1. View

Toker A, Newton A . Cellular signaling: pivoting around PDK-1. Cell. 2000; 103(2):185-8. DOI: 10.1016/s0092-8674(00)00110-0. View

Simpson L, Parsons R . PTEN: life as a tumor suppressor. Exp Cell Res. 2001; 264(1):29-41. DOI: 10.1006/excr.2000.5130. View

10.

Beauloye C, Bertrand L, Krause U, Marsin A, Dresselaers T, Vanstapel F . No-flow ischemia inhibits insulin signaling in heart by decreasing intracellular pH. Circ Res. 2001; 88(5):513-9. DOI: 10.1161/01.res.88.5.513. View

11.

Jovanovic S, Jovanovic A . Pinacidil prevents membrane depolarisation and intracellular Ca2+ loading in single cardiomyocytes exposed to severe metabolic stress. Int J Mol Med. 2001; 7(6):639-43. DOI: 10.3892/ijmm.7.6.639. View

12.

Alessi D . Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture. Biochem Soc Trans. 2001; 29(Pt 2):1-14. DOI: 10.1042/0300-5127:0290001. View

13.

Cho K, Lee J, Kim S, Kim D, Koh H, Lee J . Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway. Proc Natl Acad Sci U S A. 2001; 98(11):6144-9. PMC: 33436. DOI: 10.1073/pnas.101596998. View

14.

Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

15.

Cesselli D, Jakoniuk I, Barlucchi L, Beltrami A, Hintze T, Nadal-Ginard B . Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res. 2001; 89(3):279-86. DOI: 10.1161/hh1501.094115. View

16.

Lawlor M, Mora A, Ashby P, Williams M, Murray-Tait V, Malone L . Essential role of PDK1 in regulating cell size and development in mice. EMBO J. 2002; 21(14):3728-38. PMC: 126129. DOI: 10.1093/emboj/cdf387. View

17.

Wick A, Wick W, Waltenberger J, Weller M, Dichgans J, Schulz J . Neuroprotection by hypoxic preconditioning requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci. 2002; 22(15):6401-7. PMC: 6758162. DOI: 20026672. View

18.

Biondi R, Komander D, Thomas C, Lizcano J, Deak M, Alessi D . High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site. EMBO J. 2002; 21(16):4219-28. PMC: 126174. DOI: 10.1093/emboj/cdf437. View

19.

McManus E, Alessi D . TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat Cell Biol. 2002; 4(9):E214-6. DOI: 10.1038/ncb0902-e214. View

20.

Condorelli G, Drusco A, Stassi G, Bellacosa A, Roncarati R, Iaccarino G . Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A. 2002; 99(19):12333-8. PMC: 129445. DOI: 10.1073/pnas.172376399. View